Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
685.4 INR | -3.65% | -2.96% | +25.58% |
30/05 | Jubilant Pharmova Narrows Loss in Fiscal Q4 | MT |
29/05 | India's Jubilant Pharmova reports narrower fourth-quarter loss | RE |
Sales 2022 | 61.3B 735M | Sales 2023 | 62.82B 753M | Capitalization | 44.42B 533M |
---|---|---|---|---|---|
Net income 2022 | 4.14B 49.62M | Net income 2023 | -610M -7.31M | EV / Sales 2022 | 1.37 x |
Net Debt 2022 | 22.03B 264M | Net Debt 2023 | 26.44B 317M | EV / Sales 2023 | 1.13 x |
P/E ratio 2022 |
14.9
x | P/E ratio 2023 |
-72.8
x | Employees | 5,778 |
Yield 2022 |
1.29% | Yield 2023 |
1.79% | Free-Float | 35.19% |
1 day | -3.65% | ||
1 week | -2.96% | ||
1 month | +1.83% | ||
3 months | +20.83% | ||
6 months | +59.40% | ||
Current year | +25.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 23/17/23 | |
Chief Executive Officer | 37 | 23/17/23 | |
Arvind Chokhany
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 01/82/01 | |
Chairman | 71 | 21/78/21 | |
Chief Executive Officer | 46 | 23/17/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 34 M€ | +3.86% | - | |
0.00% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 685.4 | -3.65% | 17,847 |
30/24/30 | 711.3 | +0.79% | 259,330 |
29/24/29 | 705.7 | +0.26% | 54,550 |
28/24/28 | 703.9 | +1.98% | 9,711 |
27/24/27 | 690.2 | -2.27% | 9,440 |
Delayed Quote Bombay S.E., May 31, 2024 at 03:30 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+25.58% | 1.31B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- JUBLPHARMA Stock